Affinity Chromatography Market Revenue to Attain USD 8.98 Bn by 2035

Published: 07 Apr 2026

Author: Precedence Research

Share:

Affinity Chromatography Market Revenue and Trends 2026 to 2035

The affinity chromatography market revenue surpassed USD 3.90 billion in 2025 and is predicted to attain around USD 8.98 billion by 2035 with a CAGR of 8.70% during the forecast period. The market is driven by increasing biologics production and the demand for highly precise and efficient molecular purification in biopharmaceutical manufacturing.

Market Overview

The affinity chromatography market focuses on a purification technique that emphasizes biological selectivity, capturing target molecules through highly specific interactions between ligands and their binding partners. The market spans a wide range of tools, resins, and systems used to isolate proteins, antibodies, and enzymes for both research and large-scale biomanufacturing. It is distinguished not only by its functionality but also by its ability to meet the stringent purity standards required for modern therapeutics.

The scope of affinity chromatography spans from laboratory-scale research to large-scale industrial applications, including drug discovery, vaccine development, and next-generation therapeutics such as cell and gene therapies. The market integrates consumables with automated systems and continuously advances resin technologies to enhance specificity, reusability, and overall efficiency.

What are the Emerging Opportunities in the Market?

• Development of Next-Generation Affinity Systems: Next-generation affinity systems are pushing the boundaries of efficiency and precision. For instance, TriAltus’ im7 resin demonstrates a binding capacity ranging from approximately 20 mg/mL to 40 mg/mL, with purity levels reaching up to 100%, setting new standards for operational performance. Moving forward, competition in the market is expected to focus less on availability and more on metrics such as binding capacity, selectivity, and resin lifecycle.
• Rising Vaccine Production: The rising production of vaccines is creating significant opportunities in the affinity chromatography market because vaccines require highly pure and consistent biologics, which rely on efficient purification technologies. High-throughput vaccine manufacturing, especially for mRNA, viral vector, and protein-based vaccines, drives demand for advanced affinity resins and automated systems that can improve yield, speed, and reproducibility. Additionally, the need for rapid-response capabilities in pandemic situations further increases reliance on flexible, scalable, and high-performance affinity chromatography platforms.

How Government Investments Contribute to the Market?

Government investments drive the affinity chromatography market by funding research infrastructure, supporting the development of advanced biologics, and accelerating innovation in purification technologies. Grants and subsidies help both academic institutions and biopharmaceutical companies adopt state-of-the-art systems, improve workflow efficiency, and scale up production. Additionally, regulatory support and public funding for vaccine and therapeutic development create a steady demand for high-performance affinity chromatography platforms, further expanding market growth.

• The Union Budget 2026-27 proposed Biopharma SHAKTI, allocating Rs. 10,000 crores over five years to boost India’s biologics and biosimilars production and target a 5% share of the global biopharmaceutical industry.

Market Segmentation Overview

• By product, the resins segment held a major revenue share of 58% in the affinity chromatography market in 2025, driven by their critical role in biopharmaceutical purification, where strict quality standards are essential. Their high binding capacity makes them indispensable in monoclonal antibody production, where both yield and purity are crucial. As biologics production volumes grow and resin technologies advance, resins remain central to downstream processing strategies.
• By product, the kits & reagents segment is expected to grow at the highest CAGR in the market during the studied years, owing to the demand for ready-to-use solutions that simplify laboratory workflows. These products reduce pre-processing steps and variability, making them highly desirable for time-sensitive research and efficiency-driven applications.
• By technique, the protein A affinity chromatography segment held a major revenue share of 48% in 2025, mainly due to its widespread use in antibody purification. Its high specificity and efficiency have made it an essential tool in downstream bioprocessing workflows.
• By application, the antibody purification segment led the global affinity chromatography market in 2025, driven by rapid growth in monoclonal antibody therapies. High specificity and reproducibility make affinity chromatography essential for commercial manufacturing, where accurate and scalable purification methods remain critical.
• By application, the vaccine production segment is expected to grow at the fastest CAGR in the market between 2026 and 2035, driven by the need for rapid and scalable manufacturing solutions. Affinity chromatography ensures the precision required for complex vaccine components, and global immunization efforts, coupled with technological advances, are expected to further expand this segment.
• By end user, the pharmaceutical & biotechnology companies segment accounted for the largest share of 60% in 2025, owing to their large-scale biologics pipeline and significant R&D investments. Affinity chromatography has become a vital component of workflows, as even minor variations can affect entire batches in both development and commercial manufacturing.
• By end user, the contract research organizations (CROs) segment is expected to grow at the fastest rate between 2026 and 2035, driven by the outsourcing trend in drug development. CROs equipped with advanced purification technologies offer flexible, cost-effective solutions that accelerate project turnaround, making them key enablers for internal teams and boosting demand for affinity chromatography.

Regional Insights

North America dominated the affinity chromatography market with a share of 38% in 2025 due to its large biopharmaceutical industry, substantial R&D investments, and early adoption of advanced purification technologies. The strong demand for biologics, combined with well-established academic research and industrial infrastructure, further strengthened the region’s market position. Additionally, the U.S. and Canada contributed through large-scale biologics production, innovative technology deployment, and collaborations between industry and academia.

Asia Pacific held a 23% share of the market in 2025 and is expected to grow at the fastest CAGR in the upcoming period, driven by expanding biopharmaceutical manufacturing and significant regional investments. Government initiatives, including funding, infrastructure development, and favorable policies, are actively supporting growth. China and India are emerging as key players, with expanding biologics production and clinical trials, transforming the region into a hub for purification technologies through cost-effective manufacturing and enhanced R&D efforts.

Affinity Chromatography Market Coverage

Top Companies in the Market

Key players in the market are driving innovation and setting industry standards. Cytiva, part of Danaher Corporation, provides essential resins and columns used across biologics workflows, often defining benchmarks for performance and reliability. Bio-Rad Laboratories, Inc. and Agilent Technologies, Inc. contribute analytical expertise that strengthens purification and validation processes, while Sartorius AG focuses on integrated bioprocess platforms that seamlessly connect upstream and downstream operations.

Segments Covered in the Report

By Product

• Resins 
  
  • Protein A Resins
  • Protein G Resin
  • Immobilized Metal Affinity Chromatography (IMAC) Resins
  • Dye Ligand Resins
• Columns
  
  • Prepacked Columns
  • Empty Columns
• Kits & Reagent
  
  • Buffers
  • Elution Reagents
  • Purification Kits

By Application

• Antibody Purification
  
  • Monoclonal Antibodie 
  • Polyclonal Antibodies
• Protein Purification
  
  • Recombinant Proteins
  • Enzyme
• Vaccine Production
• Others
  
  • Biomarker Discovery
  • Diagnostics

By End User

• Pharmaceutical & Biotechnology Companies
  
  • Biopharmaceutical Manufacturers
  • Vaccine Manufacturers
• Academic & Research Institutes
  
  • Universities
  • Research Labs
• Contract Research Organization

By Technique

• Protein A Affinity Chromatography
• Immobilized Metal Affinity Chromatography (IMAC)
• Dye-Ligand Chromatography
• Others
  
  • Lectin Affinity Chromatography
  • Immunoaffinity Chromatography

By Region

• North America
• Asia Pacific
• Europe
• South America
• MEA

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8277

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344